Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Setting dissolution specifications for modified-release dosage forms

D A Piscitelli1, D Young

  • 1Pharmacokinetics-Biopharmaceutics Laboratory, School of Pharmacy, University of Maryland at Baltimore 21201, USA.

Advances in Experimental Medicine and Biology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco-Tronic system.

Transfusion medicine (Oxford, England)·2001
Same author

How "abundance thinking" can change your life.

The Journal of the Michigan Dental Association·2001
Same author

Examination of Y-STR mutations in sex chromosomal abnormality in forensic cases.

Forensic science international·2001
Same author

Pho23 is associated with the Rpd3 histone deacetylase and is required for its normal function in regulation of gene expression and silencing in Saccharomyces cerevisiae.

The Journal of biological chemistry·2001
Same author

Long-term follow-up on an intensified treatment regimen for advanced resectable head and neck squamous cell carcinomas.

Cancer investigation·2001
Same author

Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer.

Diseases of the colon and rectum·2001
Same journal

Mammalian Respiratory Chain Complex Assemblies and Their Links to Mitochondria Stress-Induced Human Diseases.

Advances in experimental medicine and biology·2026
Same journal

Enzyme Assemblies in Nucleotide Metabolism: Structure, Regulation, and Disease Implications.

Advances in experimental medicine and biology·2026
Same journal

The Pyruvate Dehydrogenase Complex: A 90-Year-Old Enigma Shaping the Future of Structural Enzymology.

Advances in experimental medicine and biology·2026
Same journal

Regulation of the Anti-termination RNA Transcription Complex by Lon-Mediated Lambda N Degradation.

Advances in experimental medicine and biology·2026
Same journal

PCNA Macromolecular Complexes: PCNA Serves as a Molecular Hub Regulating Multiple Cellular Processes Inside and Outside of the Nucleus.

Advances in experimental medicine and biology·2026
Same journal

Dynamic Assemblies in Genome Maintenance.

Advances in experimental medicine and biology·2026
See all related articles

Setting dissolution specifications is crucial for quality assurance and predicting in vivo bioavailability. Properly established limits ensure bioequivalence of formulations, guiding development and reducing the need for extensive studies.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery and Formulation

Background:

  • Dissolution specifications are vital for pharmaceutical quality assurance.
  • They can serve as surrogates for in vivo bioavailability, influencing formulation development.
  • Current methods for setting these specifications are under review.

Purpose of the Study:

  • To review various methods for establishing dissolution specifications.
  • To highlight key considerations for selecting an appropriate method.
  • To ensure that dissolution specifications predict in vivo performance and bioequivalence.

Main Methods:

  • Review of existing methodologies for setting dissolution specifications.
  • Analysis of advantages and disadvantages of each method (Table 1).
  • Emphasis on incorporating in vivo data, intersubject variability, and plasma concentration-time profile predictions.

Related Experiment Videos

Main Results:

  • Several methods for setting dissolution specifications exist, each with pros and cons.
  • Effective methods require a discriminating dissolution system and in vivo data.
  • Predicting plasma concentration-time profiles aids in assessing formulation performance.

Conclusions:

  • Dissolution specifications should guarantee bioequivalence for formulations within specified limits.
  • Testing the boundaries of specifications for bioequivalence is recommended.
  • Population predictions of plasma concentration-time profiles should account for intersubject variability.